电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Calbindin (CALB1) (C-Term) Peptide

CALB1 适用: 人 宿主: 合成 BP, WB, IHC
产品编号 ABIN974397
发货至: 中国

Quick Overview for Calbindin (CALB1) (C-Term) Peptide (ABIN974397)

抗原

CALB1 (Calbindin (CALB1))

宿主

资源

  • 5
合成

应用范围

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • 蛋白结构域

    C-Term

    序列

    EFNKAFELYD QDGNGYIDEN ELDALLKDLC EKNKQDLDIN NITTYKKNIM

    产品特性

    This is a synthetic peptide designed for use in combination with anti-CALB1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    纯化方法

    Purified
  • 应用备注

    Each Investigator should determine their own optimal working dilution for specific applications.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    浓度

    1 mg/mL

    缓冲液

    Final peptide concentration is 1 mg/mL in PBS.

    注意事项

    Avoid repeated freeze-thaw cycles.

    储存条件

    -20 °C

    储存方法

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • 抗原

    CALB1 (Calbindin (CALB1))

    背景

    Calbindin is a calcium-binding protein belonging to the troponin C superfamily. It was originally described as a 27-kD protein induced by vitamin D in the duodenum of the chick. In the brain, its synthesis is independent of vitamin-D-derived hormones. Calbindin contains 4 active calcium-binding domains, and 2 modified domains that presumably have lost their calcium-binding capacity. The neurons in brains of patients with Huntington disease are calbindin-depleted.

    Alias Symbols: CALB

    Protein Interaction Partner: IMPA1,RANBP9,TRPV5,TRPV6,IKBKG,IMPA1,RANBP9

    Protein Size: 261

    分子量

    30 kDa

    基因ID

    793

    NCBI登录号

    NM_004929, NP_004920

    UniProt

    P05937
You are here:
Chat with us!